A revolutionary treatment, retatrutide, is sparking considerable excitement within the Aussie weight loss community. Designed by Eli Lilly , this twin GIP and GLP-1 receptor appears to provide more substantial results than existing therapies. Preliminary scientific trials have shown remarkable re